PROTEASE INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS
The application relates to compounds of Formula (I) and (III), their pharmaceutically acceptable salts, and their pharmaceutical compositions. The compounds are potent inhibitors of the main protease (M.
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 21. Dez. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
CHATTERJEE ARNAB [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-12-21, Last update posted on www.tib.eu: 2024-05-06, Last updated: 2024-05-10 |
|---|
| Patentnummer: |
AU2022290865 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA000707147 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA000707147 | ||
| 003 | DE-627 | ||
| 005 | 20240510112701.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240315s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA000707147 | ||
| 035 | |a (EPA)AU2022290865 | ||
| 035 | |a (EPA)82403440 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a CHATTERJEE ARNAB |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PROTEASE INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-12-21, Last update posted on www.tib.eu: 2024-05-06, Last updated: 2024-05-10 | ||
| 520 | |a The application relates to compounds of Formula (I) and (III), their pharmaceutically acceptable salts, and their pharmaceutical compositions. The compounds are potent inhibitors of the main protease (M | ||
| 650 | 4 | |a C07F: Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium (metal-containing porphyrins c07d0487220000;macromolecular compounds c08) | |
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a C07C: Acyclic or carbocyclic compounds (macromolecular compounds c08;production of organic compounds by electrolysis or electrophoresis c25b0003000000, c25b0007000000) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a CHEN JIAN |e verfasserin |4 aut | |
| 700 | 0 | |a NAKATH ELSHAN |e verfasserin |4 aut | |
| 700 | 0 | |a RAHIMI ALIREZA |e verfasserin |4 aut | |
| 700 | 0 | |a GUPTA ANIL |e verfasserin |4 aut | |
| 700 | 0 | |a GRABOVYI GENNADII |e verfasserin |4 aut | |
| 700 | 0 | |a WILSON KATY |e verfasserin |4 aut | |
| 700 | 0 | |a GHORAI SOURAV |e verfasserin |4 aut | |
| 700 | 0 | |a NAZARIAN ARMEN |e verfasserin |4 aut | |
| 700 | 0 | |a PEDROARENA JAMES |e verfasserin |4 aut | |
| 700 | 0 | |a MAZUMDAR WRICKBAN |e verfasserin |4 aut | |
| 700 | 0 | |a WEISS FRANK |e verfasserin |4 aut | |
| 700 | 0 | |a SONG LIRUI |e verfasserin |4 aut | |
| 700 | 0 | |a BAKOWSKI MALINA |e verfasserin |4 aut | |
| 700 | 0 | |a RIVA LAURA |e verfasserin |4 aut | |
| 700 | 0 | |a WOLFF KAREN |e verfasserin |4 aut | |
| 700 | 0 | |a MCNAMARA CASE |e verfasserin |4 aut | |
| 700 | 0 | |a ROGERS THOMAS |e verfasserin |4 aut | |
| 700 | 0 | |a MALVIN JACQUELINE |e verfasserin |4 aut | |
| 700 | 0 | |a LI SHUANGWEI |e verfasserin |4 aut | |
| 700 | 0 | |a JOSEPH SEAN |e verfasserin |4 aut | |
| 700 | 0 | |a WOODS ASHLEY |e verfasserin |4 aut | |
| 700 | 0 | |a LIU YUYIN LIU |e verfasserin |4 aut | |
| 700 | 0 | |a OKWOR NEECHI |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 21. Dez. |
| 773 | 1 | 8 | |g year:2023 |g day:21 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/82403440/publication/AU2022290865A1?q=AU2022290865 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 21 |c 12 | ||